The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
CRISPR–Cas9-assisted recombineering in Lactobacillus reuteri
Open accessAbstract
Clustered regularly interspaced palindromic repeats (CRISPRs) and the CRISPR-associated (Cas) nuclease protect bacteria and archeae from foreign DNA by site-specific cleavage of incoming DNA. Type-II CRISPR-Cas systems, such as the Streptococcus pyogenes CRISPR-Cas9 system, can be adapted such that Cas9 can be guided to a user-defined site in the chromosome to introduce double-stranded breaks. Here we have developed and optimized CRISPR-Cas9 function in the lactic acid bacterium Lactobacillus reuteri ATCC PTA 6475. We established proof-of-concept showing that CRISPR-Cas9 selection combined with single-stranded DNA (ssDNA) recombineering is a realistic approach to identify at high efficiencies edited cells in a lactic acid bacterium. We show for three independent targets that subtle changes in the bacterial genome can be recovered at efficiencies ranging from 90 to 100%. By combining CRISPR-Cas9 and recombineering, we successfully applied codon saturation mutagenesis in the L. reuteri chromosome. Also, CRISPR-Cas9 selection is critical to identify low-efficiency events such as oligonucleotide-mediated chromosome deletions. This also means that CRISPR-Cas9 selection will allow identification of recombinant cells in bacteria with low recombineering efficiencies, eliminating the need for ssDNA recombineering optimization procedures. We envision that CRISPR-Cas genome editing has the potential to change the landscape of genome editing in lactic acid bacteria, and other Gram-positive bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Enzymatic assembly of DNA molecules up to several hundred kilobases
Gibson, D. G., Young, L., Chuang, R.-Y., Venter, J. C., Hutchison, C. A., & Smith, H. O. (2009) · Nature Methods · doi:10.1038/nmeth.1318 · Cited by 9,996
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
CRISPR/Cas, the Immune System of Bacteria and Archaea
Horvath, P., & Barrangou, R. (2010) · Science · doi:10.1126/science.1179555 · Cited by 2,465
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993 · cited 1×
“pyogenes CRISPR–Cas9 system cleaves target DNA efficiently if non-homologous bases at position 21–28 are present in the protospacer, whereas a protospacer of 17 base pairs still yields efficient targeting by Cas9 (43,44).”
BackgroundRNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851
Programming cells by multiplex genome engineering and accelerated evolution
Wang, H. H., Isaacs, F. J., Carr, P. A., Sun, Z. Z., Xu, G., Forest, C. R., & Church, G. M. (2009) · Nature · doi:10.1038/nature08187 · Cited by 1,529 · cited 1×
“Also, our work combined with current developments in CRISPR–Cas9 genome editing makes the application of MAGE in lactobacilli and bifidobacteria tantalizing, yet not unreasonable (45,46).”
BackgroundTreatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10
Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., & Remaut, E. (2000) · Science · doi:10.1126/science.289.5483.1352 · Cited by 1,513
Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases
Cho, S. W., Kim, S., Kim, Y., Kweon, J., Kim, H. S., Bae, S., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.162339.113 · Cited by 1,356
Holo, H., & Nes, I. F. (1989) · Applied and Environmental Microbiology · doi:10.1128/aem.55.12.3119-3123.1989 · Cited by 1,048
Salminen, S. (1993) · Medical Entomology and Zoology · Cited by 659
Recombineering in Mycobacterium tuberculosis
van Kessel, J. C., & Hatfull, G. F. (2007) · Nature Methods · doi:10.1038/nmeth996 · Cited by 581
Ellis, H. M., Yu, D., DiTizio, T., & Court, D. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121164898 · Cited by 564
Lactic acid bacteria as probiotics.
Ljungh, Å., & Wadström, T. (2006) · PubMed · Cited by 542
Probiotic L. reuteri Treatment Prevents Bone Loss in a Menopausal Ovariectomized Mouse Model
Britton, R. A., Irwin, R., Quach, D., Schaefer, L., Zhang, J., Lee, T., Parameswaran, N., & McCabe, L. R. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24636 · Cited by 499
Thomas, C. M., Hong, T., van Pijkeren, J. P., Hemarajata, P., Trinh, D. V., Hu, W., Britton, R. A., Kalkum, M., & Versalovic, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031951 · Cited by 491
Mismatch amplification mutation assay (MAMA): application to the c-H-ras gene.
Cha, R. S., Zarbl, H., Keohavong, P., & Thilly, W. G. (1992) · Genome Research · doi:10.1101/gr.2.1.14 · Cited by 378
The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems
Chylinski, K., Le Rhun, A., & Charpentier, E. (2013) · RNA Biology · doi:10.4161/rna.24321 · Cited by 353
Spinler, J. K., Taweechotipatr, M., Rognerud, C. L., Ou, C. N., Tumwasorn, S., & Versalovic, J. (2008) · Anaerobe · doi:10.1016/j.anaerobe.2008.02.001 · Cited by 332
Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis
Vaghef-Mehrabany, E., Alipour, B., Homayouni-Rad, A., Sharif, S.-K., Asghari-Jafarabadi, M., & Zavvari, S. (2014) · Nutrition · doi:10.1016/j.nut.2013.09.007 · Cited by 311
Probiotics and health: An evidence-based review
Aureli, P., Capurso, L., Castellazzi, A. M., Clerici, M., Giovannini, M., Morelli, L., Poli, A., Pregliasco, F., Salvini, F., & Zuccotti, G. V. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.02.006 · Cited by 281
Enhanced levels of λ Red-mediated recombinants in mismatch repair mutants
Costantino, N., & Court, D. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434959100 · Cited by 275
Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun
Lin, Y. P., Thibodeaux, C. H., Peña, J. A., Ferry, G. D., & Versalovic, J. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20448 · Cited by 234
Biology of Microorganisms on Grapes, in Must and in Wine
(2017) · Springer eBooks · doi:10.1007/978-3-319-60021-5 · Cited by 230
CRISPR‐Cas systems and RNA‐guided interference
Barrangou, R. (2013) · WIREs RNA · doi:10.1002/wrna.1159 · Cited by 227
High efficiency recombineering in lactic acid bacteria
van Pijkeren, J.-P., & Britton, R. A. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks147 · Cited by 226
Self-citationClarke, G., Cryan, J. F., Dinan, T. G., & Quigley, E. M. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04965.x · Cited by 216
G-AlegrıÌa, E., López, I., Ruiz, J. I., Sáenz, J., Fernández, E., Zarazaga, M., Dizy, M., Torres, C., & Ruiz-Larrea, F. (2004) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00854-1 · Cited by 206
Datta, S., Costantino, N., Zhou, X., & Court, D. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709089105 · Cited by 198
Modelling strategies for the industrial exploitation of lactic acid bacteria
Teusink, B., & Smid, E. J. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1319 · Cited by 174
Sawitzke, J. A., Costantino, N., Li, X.-T., Thomason, L. C., Bubunenko, M., Court, C., & Court, D. L. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.01.030 · Cited by 158
Characterization of a gram-positive broad-host-range plasmid isolated from Lactobacillus hilgardii
Josson, K., Scheirlinck, T., Michiels, F., Platteeuw, C., Stanssens, P. E., Joos, H., D’Haese, P. C., Zabeau, M., & Mahillon, J. (1989) · Plasmid · doi:10.1016/0147-619x(89)90082-6 · Cited by 143
Multivitamin production in Lactococcus lactis using metabolic engineering
Sybesma, W., Burgess, C., Starrenburg, M., van Sinderen, D., & Hugenholtz, J. (2003) · Metabolic Engineering · doi:10.1016/j.ymben.2003.11.002 · Cited by 138
Diversity of lactic acid bacteria of the bioethanol process
de Lucena, B. T. L., dos Santos, B. M., Moreira, J. L., Moreira, A. P. B., Nunes, Á. C., Azevedo, V., Miyoshi, A., Thompson, F. L., & de Morais, M. A. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-298 · Cited by 124
Plasmid rolling‐circle replication: recent developments
Khan, S. A. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02001.x · Cited by 115
Gaspar, P., Neves, A. R., Ramos, A., Gasson, M. J., Shearman, C. A., & Santos, H. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.3.1466-1474.2004 · Cited by 103
Recombinant lactic acid bacteria as mucosal biotherapeutic agents
Daniel, C., Roussel, Y., Kleerebezem, M., & Pot, B. (2011) · Trends in biotechnology · doi:10.1016/j.tibtech.2011.05.002 · Cited by 102
van Pijkeren, J., Neoh, K. M., Sirias, D., Findley, A. S., & Britton, R. A. (2012) · Bioengineered · doi:10.4161/bioe.21049 · Cited by 82
König, H., & Fröhlich, J. (2008) · Springer eBooks · doi:10.1007/978-3-540-85463-0_1 · Cited by 80
Eaton, K. A., Honkala, A. T., Auchtung, T. A., & Britton, R. A. (2010) · Infection and Immunity · doi:10.1128/iai.00880-10 · Cited by 73
Engineering lactic acid bacteria for increased industrial functionality
Bron, P. A., & Kleerebezem, M. (2011) · Bioengineered Bugs · doi:10.4161/bbug.2.2.13910 · Cited by 71
The involvement of replication in single stranded oligonucleotide-mediated gene repair
Huen, M. S. Y., Li, X., Lu, L., Watt, R. M., Liu, D., & Huang, J. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl852 · Cited by 58
Ahrné, S., Molin, G., & Axelsson, L. T. (1992) · Current Microbiology · doi:10.1007/bf01579282 · Cited by 45
Folate overproduction inLactobacillus plantarumWCFS1 causes methotrexate resistance
Wegkamp, A., de Vos, W. M., & Smid, E. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01690.x · Cited by 16
Cited by
Applications of CRISPR technologies in research and beyond
Barrangou, R., & Doudna, J. A. (2016) · Nature Biotechnology · doi:10.1038/nbt.3659 · Cited by 1,005
CRISPR-Cas immunity in prokaryotes
Marraffini, L. A. (2015) · Nature · doi:10.1038/nature15386 · Cited by 829
Ishino, Y., Krupovic, M., & Forterre, P. (2018) · Journal of Bacteriology · doi:10.1128/jb.00580-17 · Cited by 558
Sun, Z., Harris, H. M. B., McCann, A., Guo, C., Argimón, S., Zhang, W., Yang, X., Jeffery, I. B., Cooney, J. C., Kagawa, T. F., et al. (2015) · Nature Communications · doi:10.1038/ncomms9322 · Cited by 543
Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies
Aggarwal, N., Kitano, S., Puah, G. R. Y., Kittelmann, S., Hwang, I. Y., & Chang, M. W. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00431 · Cited by 508
Metadata
- Authors
- Oh, J.-H., & van Pijkeren, J.-P.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-07-29
- Volume
- 42
- Issue
- 17
- Pages
- e131-e131
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2119633529
- Cited by
- 392
- References
- 46
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.